Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey.

Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey.

Measles and rubella are highly contagious viral diseases transmitted via respiratory secretions and aerosolized droplets. Thailand has implemented universal vaccination against measles using the monovalent measles (M) or the trivalent measles-mumps-rubella (MMR) vaccine for the past 30 years. Nevert...

Full description

Bibliographic Details
Main Authors:	Nasamon Wanlapakorn, Rujipat Wasitthankasem, Preeyaporn Vichaiwattana, Chompoonut Auphimai, Pornsak Yoocharoen, Sompong Vongpunsawad, Yong Poovorawan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0225606

Similar Items

Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.
by: Nasamon Wanlapakorn, et al.
Published: (2016-01-01)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
by: Rujipat Wasitthankasem, et al.
Published: (2017-11-01)

Towards the elimination of viral hepatitis in Thailand by the year 2030
by: Nawarat Posuwan, et al.
Published: (2020-09-01)

Antibodies to Bordetella pertussis antigens in maternal and cord blood pairs: a Thai cohort study
by: Nasamon Wanlapakorn, et al.
Published: (2017-11-01)

Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand.
by: Pornpitra Pratedrat, et al.
Published: (2023-01-01)

Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand
by: Pornpitra Pratedrat, et al.
Published: (2023-01-01)

High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand
by: Siripat Pasittungkul, et al.
Published: (2022-12-01)

Respiratory syncytial virus, human metapneumovirus, and influenza virus infection in Bangkok, 2016-2017
by: Ilada Thongpan, et al.
Published: (2019-04-01)

The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.
by: Nawarat Posuwan, et al.
Published: (2016-01-01)

Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
by: Nawarat Posuwan, et al.
Published: (2018-01-01)

Serological evidence of hepatitis A, B, and C virus infection in older adults in Khon Kaen, Thailand and the estimated rates of chronic hepatitis B and C virus infection in Thais, 2017
by: Nawarat Posuwan, et al.
Published: (2019-08-01)

Enterovirus A71 Infection, Thailand, 2017
by: Jiratchaya Puenpa, et al.
Published: (2018-07-01)

Respiratory syncytial virus genotypes NA1, ON1, and BA9 are prevalent in Thailand, 2012–2015
by: Ilada Thongpan, et al.
Published: (2017-10-01)

Epidemiology and clinical characteristics of severe acute respiratory infections among hospitalized children under 5 years of age in a tertiary care center in Bangkok, Thailand, 2019–2020
by: Nasamon Wanlapakorn, et al.
Published: (2023-11-01)

Recombinant GII.Pe-GII.4 Norovirus, Thailand, 2017–2018
by: Watchaporn Chuchaona, et al.
Published: (2019-08-01)

Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy.
by: Rujipat Wasitthankasem, et al.
Published: (2018-01-01)

Correction: Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.
by: Rujipat Wasitthankasem, et al.
Published: (2016-01-01)

Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.
by: Rujipat Wasitthankasem, et al.
Published: (2017-01-01)

The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region
by: Jiratchaya Puenpa, et al.
Published: (2019-10-01)

Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study.
by: Rujipat Wasitthankasem, et al.
Published: (2018-01-01)

Chikungunya Outbreak in Bueng Kan Province, Thailand, 2013
by: Nasamon Wanlapakorn, et al.
Published: (2014-08-01)

Climate factors influence seasonal influenza activity in Bangkok, Thailand.
by: Nungruthai Suntronwong, et al.
Published: (2020-01-01)

Rotavirus infection in children in Southeast Asia 2008–2018: disease burden, genotype distribution, seasonality, and vaccination
by: Fajar Budi Lestari, et al.
Published: (2020-05-01)

Characterizing genetic and antigenic divergence from vaccine strain of influenza A and B viruses circulating in Thailand, 2017–2020
by: Nungruthai Suntronwong, et al.
Published: (2021-01-01)

Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.
by: Vo Duy Thong, et al.
Published: (2015-01-01)

Climate factors influence seasonal influenza activity in Bangkok, Thailand
by: Nungruthai Suntronwong, et al.
Published: (2020-01-01)

Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand.
by: Sompong Vongpunsawad, et al.
Published: (2017-01-01)

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
by: Nasamon Wanlapakorn, et al.
Published: (2022-01-01)

Declining Trend of Hepatitis A Seroepidemiology in Association with Improved Public Health and Economic Status of Thailand.
by: Pattaratida Sa-nguanmoo, et al.
Published: (2016-01-01)

Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series
by: Wonngarm Kittanamongkolchai, et al.
Published: (2021-12-01)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
by: Heijstek MW, et al.
Published: (2008-09-01)

Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia.
by: Rujipat Wasitthankasem, et al.
Published: (2015-01-01)

Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand
by: Teeraporn Chinchai, et al.
Published: (2019-10-01)

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
by: L Sticchi, et al.
Published: (2019-12-01)

Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination
by: Nungruthai Suntronwong, et al.
Published: (2022-07-01)

One single-center serological survey on measles, rubella and mumps antibody levels of people in Youyang, China
by: Qing Wang, et al.
Published: (2021-11-01)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
by: Sitthichai Kanokudom, et al.
Published: (2022-01-01)

Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014.
by: Nipaporn Tewawong, et al.
Published: (2015-01-01)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
by: T Jacob John
Published: (2023-01-01)

SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis
by: Ritthideach Yorsaeng, et al.
Published: (2023-06-01)